甲醇耐药脂酶突变体的半导体设计:通往高效生物柴油生产的途径
Junzhang Chang1, Yuxin Zhang1, Ben Xing1
1College of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui 230601, China.
Journal of agricultural and food chemistry
|March 13, 2025
概括
工程化脂酶显示出提高稳定性和活性,用于高效的生物柴油合成. 这项研究提出了使用改性酶生产生物柴油的新策略,为生物燃料生产提供了更绿色的替代方案.
科学领域:
- 生物技术是生物技术.
- 酶工程是什么? 酶工程是什么?
- 可再生能源可再生能源是可再生能源.
背景情况:
- 脂酶是生物柴油合成的关键生物催化剂.
- 提高脂酶稳定性和甲醇耐受性对于工业应用至关重要.
- 热菌兰类脂酶是酶式生物柴油生产的关键酶.
研究的目的:
- 为了提高Thermomyces lanuginosus lipase的活性和稳定性,用于生物柴油合成.
- 通过蛋白质工程开发一种耐甲醇和热稳定的脂酶.
- 为了评估工程化脂酶在单步生物柴油生产中的性能.
主要方法:
- 半导体设计结合了向突变发生和N-糖化.
- 局部定向的突变发生,以产生特定的氨基酸替代物 (例如,A113G).
- 引入N-糖化位点 (例如L74N) 以提高稳定性.
- 分子动力学模拟以了解蛋白质-酶相互作用.
主要成果:
- 与野生类型相比,A113G突变的活性增加了46%.
- 双重突变A113G/L74N在50°C的50%甲醇中化后保持了33%的活性.
- 生物柴油产量为91.2% (大豆油) 和80.6% (炸油废弃物) 的生物柴油产量是使用工程化脂酶在单步过程中实现的.
- 分子动力学模拟揭示了N-甘氨酸与蛋白质之间的稳定键.
结论:
- 工程化脂酶表现出更好的热稳定性和甲醇耐受性,适合生物柴油生产.
- 半合理的设计方法是有效的增强酶特性.
- 这项研究为酶式生物柴油合成提供了一个有希望和环保的战略.
相关概念视频
Drug Biotransformation: Overview
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Biofuels
The microbial conversion of organic matter into biofuels holds potential as a renewable energy source. Among biofuel sources, microalgae are recognized as a highly efficient and adaptable feedstock for biodiesel production, owing to their rapid biomass accumulation, elevated lipid productivity, and capacity to proliferate in diverse aquatic systems, including freshwater, marine, and wastewater habitats. Unlike terrestrial crops, microalgae do not compete for land and can achieve significantly...


